American Trust Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
American Trust Investment Advisors's LLY Position: Q2 2026 in Review
American Trust Investment Advisors reduced its Eli Lilly (LLY) stake by 5.9% in Q2 2026, selling an estimated $49K and leaving 772 shares worth $926K. The position accounts for 0.46% of the portfolio, ranked #43.
American Trust Investment Advisors first reported a position in LLY in Q2 2018 and has held it in 28 quarters since. The position peaked at $948K in Q4 2025. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- American Trust Investment Advisors held 772 shares of Eli Lilly worth $926K as of Q2 2026.
- American Trust Investment Advisors sold 48 Eli Lilly shares in Q2 2026, an estimated $49K.
- Eli Lilly made up 0.46% of American Trust Investment Advisors's portfolio in Q2 2026, its #43 holding.
- American Trust Investment Advisors first reported a position in Eli Lilly in Q2 2018 and has held it in 28 quarters since.
- American Trust Investment Advisors's Eli Lilly position peaked at $948K in Q4 2025.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on American Trust Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.